📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 15:40
21 analysed today
21
Today
136,026
All-time analysed
40,384
Positive
6,311
Negative
81,415
Neutral
7,848
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
32 announcements match the current filters (relevance ≥ 5).
₹36 Cr Rights Issue Fully Utilized; 75% Allocated to Subsidiary Margin Funding
Onelife Capital Advisors has confirmed the 100% utilization of its ₹36 crore Rights Issue proceeds as of June 30, 2026. The company deployed ₹27 crore (75% of the total) into its subsidiary, Dealmoney Commodities Private Limited, specifically for margin money requirements. The remaining ₹9 crore was used for general corporate purposes and issue expenses, with the monitoring agency, Acuité Ratings, reporting zero deviations from the original offer document. This capital injection is significant, representing approximately 225% of the company's TTM revenue.
Confidence: HIGH
What changedThe company has transitioned from the fund-raising phase to full deployment of the ₹36 crore capital, primarily into its commodity broking subsidiary.
Why it mattersFor a company with only ₹16 crore in TTM revenue, a ₹36 crore capital infusion is a major event that could significantly scale its financial services operations if managed efficiently.
Rights Issue Size: ₹36.00 CrInvestment in DCPL Subsidiary: ₹27.00 CrIssue Size vs TTM Revenue: 225%Issue Size vs Market Cap: 28.5%Unutilized Proceeds: Nil
📅 Short termThe stock may remain neutral as the full utilization was expected; the focus will now shift to operational execution using the new capital.
📈 Long termThe structural impact depends on the subsidiary's ability to generate returns on the ₹27 crore margin funding, especially given the company's historically low ROCE of 2.7%.
⚠ Risk flags
- High dependency on a single subsidiary (DCPL) for growth
- Significant promoter holding reduction from 52% to 26% over the last year
- Past regulatory history involving promoter bans
Key Highlights
Total Rights Issue proceeds of ₹36.00 crore have been fully utilized as of June 30, 2026.
₹27.00 crore was invested in subsidiary Dealmoney Commodities Private Limited for margin funding.
₹8.64 crore utilized for General Corporate Purposes, including ₹1.50 crore for business advances and ₹1.50 crore for real estate subsidiary investment.
Monitoring Agency Acuité Ratings & Research Limited reported zero deviations in fund utilization.
Issue size of ₹36 crore is substantial compared to the company's current market cap of ₹126 crore.
👀 What to Watch
Investors should monitor the upcoming quarterly results of the subsidiary Dealmoney Commodities Private Limited to see if the ₹27 crore capital injection translates into higher brokerage or interest income.
₹1.76 Cr PAT in Q1 FY27; Full Utilization of ₹36 Cr Rights Issue Proceeds
Onelife Capital Advisors reported a standalone net profit of ₹1.76 Cr for Q1 FY27, a significant turnaround from a loss of ₹0.62 Cr in the year-ago period. The company has fully utilized the ₹36 Cr proceeds from its 2025 Rights Issue, with the final 25% deployed during this quarter. Key corporate actions include an additional ₹1.50 Cr investment in its real estate subsidiary and the acquisition of ₹2.37 Cr in fixed assets from its commodities subsidiary. A nominal dividend of ₹0.01 per share has been recommended for FY26.
Confidence: HIGH
What changedThe company has transitioned from a loss-making Q1 to profitability and has finished the deployment phase of its major capital raise.
Why it mattersFull utilization of the Rights Issue proceeds (which was large relative to market cap) indicates the company is now fully positioned in its intended business verticals, including commodities and real estate.
Q1 Standalone PAT: ₹1.76 CrRights Issue Proceeds: ₹36.00 CrRights Issue vs Market Cap: ~32%Investment in Subsidiary: ₹1.50 CrProposed Dividend: ₹0.01 per share
📅 Short termThe return to profitability and completion of fund deployment are likely to be viewed positively by the market in the coming weeks.
📈 Long termStructural success depends on the company's ability to generate consistent returns from its diversified subsidiary portfolio and the integration of its financial services super-app.
⚠ Risk flags
- High dependency on subsidiary performance
- History of regulatory scrutiny on promoters
- Low promoter holding (26%)
Key Highlights
Standalone Revenue from Operations rose to ₹2.50 Cr in Q1 FY27 from nil in Q1 FY26.
Net Profit reached ₹1.76 Cr compared to a loss of ₹0.61 Cr in the same quarter last year.
Completed the full deployment of ₹36 Cr Rights Issue proceeds, representing ~32% of current market cap.
Invested ₹1.50 Cr to increase shareholding in Dealmoney Real Estate Private Limited to 1,42,100 shares.
Acquired fixed assets worth ₹2.37 Cr from subsidiary Dealmoney Commodities Private Limited at arm's length.
👀 What to Watch
Investors should monitor the operational performance of the 8 subsidiaries where the Rights Issue capital has been deployed, specifically looking for revenue growth in the 'Onelifetouch' platform.
Onelife Capital Reports Q1 PAT of ₹1.76 Cr; 100% of ₹36 Cr Rights Issue Fully Utilized
Onelife Capital Advisors reported a standalone turnaround in Q1 FY27 with a PAT of ₹1.76 Cr, compared to a loss of ₹0.62 Cr in the same quarter last year. The company has successfully utilized the remaining 25% of its ₹36 Cr Rights Issue proceeds for its stated objectives. Additionally, the board recommended a nominal dividend of ₹0.01 per share and approved an ESOP plan for up to 18.68 lakh shares. The company also increased its stake in its real estate subsidiary with a fresh investment of ₹1.50 Cr.
Confidence: HIGH
What changedThe company has transitioned from a loss-making quarter to profitability and has finished deploying the capital raised through its Rights Issue.
Why it mattersFull utilization of the ₹36 Cr Rights Issue (approx. 32% of market cap) indicates the company is now fully operationalizing its growth strategy across its financial and real estate verticals.
Q1 Standalone Revenue: ₹2.50 CrQ1 Standalone PAT: ₹1.76 CrRights Issue Proceeds: ₹36.00 CrRights Issue vs Market Cap: 32.1%Subsidiary Investment: ₹1.50 CrESOP Pool Size: 18,68,000 shares
📅 Short termThe turnaround in standalone profitability and the completion of fund deployment are likely to be viewed positively by the market in the coming weeks.
📈 Long termLong-term value depends on the successful integration of the 8 subsidiaries and the ability of the 'Onelifetouch' platform to generate consistent revenue after the promoter ban period ends.
⚠ Risk flags
- High dependency on subsidiary performance
- Historical regulatory issues involving promoters
- Low dividend yield
Key Highlights
Standalone PAT turned positive at ₹1.76 Cr in Q1 FY27 vs a loss of ₹0.62 Cr in Q1 FY26
Completed 100% utilization of ₹36.00 Cr Rights Issue proceeds as of June 30, 2026
Invested ₹1.50 Cr in subsidiary Dealmoney Real Estate Private Limited, increasing shareholding to 1,42,100 shares
Acquired fixed assets worth ₹2.37 Cr from subsidiary Dealmoney Commodities at arm's length price
Proposed a final dividend of 0.1% (₹0.01 per share) for FY26, subject to AGM approval
👀 What to Watch
Investors should monitor the consolidated financial performance to see if the standalone turnaround is reflected across all 8 subsidiaries and track the revenue impact of the fully deployed Rights Issue capital.
Onelife Capital Shareholders Approve CEO Appointment and Material Related Party Transactions
Onelife Capital Advisors Limited (OCAL) has announced the results of its postal ballot, where shareholders approved 11 resolutions with a requisite majority. Key approvals include the appointment of promoter Mr. Pandoo Naig as CEO and the authorization of material related party transactions (RPTs) for FY 2026-27 with seven different entities. The company also received approval for its Employee Stock Option Plan (ESOP) 2026. These approvals are critical as the company seeks to integrate its eight subsidiaries and execute a planned Rs 30 crore Rights Issue.
Confidence: HIGH
What changedThe company has formalized its leadership by appointing a CEO and secured shareholder backing for extensive inter-company financial dealings for the next fiscal year.
Why it mattersGiven OCAL's small revenue base (Rs 10 Cr TTM) and complex structure of 8 subsidiaries, these RPT approvals are essential for its 'Onelifetouch' integration strategy but also highlight high dependency on related entities.
Total Resolutions Passed: 11Assent for Item 1 (RPT): 99.91%Promoter Holding (Mar 2026): 26.03%Previous Promoter Holding (Dec 2025): 52.1%TTM Revenue: Rs 10 Cr
📅 Short termThe formalization of management and RPT frameworks provides some operational clarity, though the market may remain cautious given the historical regulatory context.
📈 Long termThe long-term success depends on the effective integration of subsidiaries and the ability of the returning CEO to drive growth without further regulatory hurdles.
⚠ Risk flags
- High volume of Material Related Party Transactions
- Significant drop in promoter holding (from 52.1% to 26.03%)
- Historical SEBI sanctions against the newly appointed CEO
- Negative operating margins (-120.0%)
Key Highlights
Appointment of Mr. Pandoo Naig as CEO approved following a previous SEBI ban period (Oct 2024 - Oct 2025).
Material Related Party Transactions approved for FY 2026-27 with entities including Family Care Hospitals and Dealmoney Group.
Approval of Onelife ESOP Plan 2026 for employees of the company and its subsidiaries.
Resolution for RPT with Family Care Hospitals passed with 99.91% assent from 504,912 votes.
Voting process involved 9,391 members via remote e-voting ending July 10, 2026.
👀 What to Watch
Investors should monitor the specific terms and financial impact of the approved Related Party Transactions, as they involve a significant portion of the company's operations. Additionally, watch for the impact of the CEO's return on corporate governance and the progress of the proposed Rs 30 crore Rights Issue.
Onelife Capital Advisors CFO Satish Kumar Resigns Effective June 20, 2026
Onelife Capital Advisors Limited has announced the resignation of Mr. Satish Kumar from the position of Chief Financial Officer (CFO) effective June 20, 2026. The resignation is attributed to personal reasons and pre-occupation, with the company confirming there are no other material reasons for his departure. As the CFO is a Key Managerial Personnel (KMP), his exit necessitates the appointment of a successor to oversee financial operations. The company has not yet named a replacement in this specific disclosure.
Key Highlights
Mr. Satish Kumar resigned as Chief Financial Officer effective from the closing hours of June 20, 2026.
The resignation is cited as being due to pre-occupation and personal reasons.
The company confirmed via a formal letter that no other material reasons exist for the resignation.
The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
👀 What to Watch
Investors should monitor future filings for the appointment of a new CFO to ensure leadership continuity and stable financial management.
Onelife Capital Seeks Shareholder Nod for RPTs, ESOP 2026, and CEO Appointment
Onelife Capital Advisors Limited has issued a postal ballot notice seeking shareholder approval for several key resolutions for the financial year 2026-27. The company is proposing material Related Party Transactions (RPTs) with seven different entities, including Family Care Hospitals and Dealmoney Commodities. Additionally, the board is seeking approval for the 'Onelife – ESOP Plan 2026' and the formal appointment of Mr. Pandoo Naig as the Chief Executive Officer with a revised remuneration structure. The e-voting period for these resolutions is set between June 11 and July 10, 2026.
Key Highlights
Approval sought for material Related Party Transactions with 7 entities for FY 2026-27.
Proposal to implement 'Onelife – Employee Stock Option Plan 2026' for company and subsidiary employees.
Appointment of Mr. Pandoo Naig as CEO and revision of his remuneration package.
Remote e-voting period starts on June 11, 2026, and concludes on July 10, 2026.
Entities involved in RPTs include Family Care Hospitals Ltd and Dealmoney Commodities Pvt Ltd.
👀 What to Watch
Investors should scrutinize the nature and scale of the material Related Party Transactions to ensure they are at arm's length and evaluate the potential equity dilution from the new ESOP 2026 plan.
Onelife Capital Recommends ₹0.01 Dividend; FY26 Net Profit Surges to ₹211 Lakhs
Onelife Capital Advisors Limited reported a strong financial performance for FY26, with standalone net profit rising to ₹211.11 lakhs from ₹50.93 lakhs in the previous year. The Board has recommended a final dividend of 0.1% (₹0.01 per share) on a face value of ₹10. Operational revenue showed a significant turnaround, reaching ₹217 lakhs compared to zero in FY25. Additionally, the company has appointed Mr. Pandoo Naig as CEO and approved a new ESOP plan for 18.68 lakh shares.
Key Highlights
Recommended a final dividend of ₹0.01 per equity share (0.1% of face value) for FY 2025-26.
Standalone net profit for the full year FY26 increased by 314% to ₹211.11 lakhs.
Revenue from operations improved to ₹217 lakhs in FY26 from nil in the previous fiscal year.
Appointed Mr. Pandoo Naig as Chief Executive Officer effective June 1, 2026.
Approved 'Onelife ESOP Plan 2026' covering up to 18,68,000 equity shares.
👀 What to Watch
Investors should monitor the company's ability to sustain the newly generated operational revenue under the leadership of the new CEO. While the dividend is nominal, the sharp recovery in profitability and the introduction of an ESOP plan suggest a focus on growth and employee retention.
Onelife Capital FY26 PAT Surges to ₹211 Lakhs; Appoints Pandoo Naig as CEO & Declares Dividend
Onelife Capital Advisors reported a significant turnaround in FY26, with standalone Profit After Tax (PAT) rising to ₹211.11 lakhs from ₹50.93 lakhs in FY25. The company generated ₹217 lakhs in operational revenue compared to zero in the previous year. The board has elevated co-founder Pandoo Naig to CEO and recommended a nominal dividend of ₹0.01 per share. Additionally, a new ESOP plan for 18.68 lakh shares was approved to incentivize employees.
Key Highlights
Standalone Net Profit increased by 314% YoY to ₹211.11 lakhs for the financial year ended March 31, 2026.
Revenue from operations reached ₹217 lakhs in FY26, a significant improvement from nil revenue in FY25.
Appointment of Mr. Pandoo Naig as Chief Executive Officer (CEO) effective June 1, 2026.
Board recommended a final dividend of 0.1% (Re. 0.01 per equity share) for the financial year.
Approved 'Onelife ESOP Plan 2026' involving the grant of up to 18,68,000 stock options.
👀 What to Watch
Investors should view the return to operational revenue and sharp profit growth as positive indicators; however, the nominal dividend and potential dilution from the new ESOP plan warrant long-term monitoring.
Onelife Capital FY26 Net Profit Jumps 314% to ₹2.11 Cr; Appoints Pandoo Naig as CEO
Onelife Capital Advisors Limited reported a strong financial performance for FY26, with standalone Net Profit rising to ₹211.11 lakhs from ₹50.93 lakhs in FY25. The fourth quarter was the primary driver, contributing ₹197.61 lakhs in profit compared to a loss of ₹61.52 lakhs in the year-ago period. The company has recommended a nominal dividend of ₹0.01 per share and announced the appointment of co-founder Pandoo Naig as CEO. Furthermore, the board approved a new ESOP plan involving 18.68 lakh shares to align employee interests with growth.
Key Highlights
Standalone Net Profit for FY26 surged 314% YoY to ₹211.11 lakhs.
Q4 FY26 Total Income stood at ₹331.59 lakhs, a massive jump from ₹2.14 lakhs in Q4 FY25.
Board recommended a final dividend of 0.1% (₹0.01 per equity share of ₹10 face value).
Mr. Pandoo Naig appointed as Chief Executive Officer (CEO) effective June 1, 2026.
Approved 'Onelife ESOP Plan 2026' for up to 18,68,000 options convertible into equity shares.
👀 What to Watch
Investors should view the sharp turnaround in Q4 and the leadership transition positively, while monitoring if the sudden revenue spike in the final quarter is sustainable in the coming fiscal.
Onelife Capital Reports FY26 Net Profit of ₹2.11 Cr, Recommends Dividend & Appoints New CEO
Onelife Capital Advisors Limited reported a strong turnaround in Q4 FY26, posting a net profit of ₹197.61 lakhs compared to a loss of ₹61.52 lakhs in the same quarter last year. For the full year ended March 31, 2026, standalone net profit grew to ₹211.11 lakhs from ₹50.93 lakhs in FY25. The company also announced a nominal final dividend of ₹0.01 per share and the appointment of co-founder Pandoo Naig as CEO. Furthermore, a new ESOP plan for up to 18.68 lakh shares was approved to incentivize employees.
Key Highlights
Standalone Net Profit for FY26 increased to ₹211.11 lakhs, up from ₹50.93 lakhs in the previous year.
Total Income for Q4 FY26 surged to ₹331.59 lakhs compared to just ₹2.14 lakhs in Q4 FY25.
Board recommended a final dividend of 0.1% (Re. 0.01 per equity share) for the financial year 2025-26.
Mr. Pandoo Naig, an Executive Director and co-founder, has been appointed as the CEO effective June 1, 2026.
Approved the 'Onelife ESOP Plan 2026' for the grant of up to 18,68,000 options convertible into equity shares.
👀 What to Watch
Investors should note the significant revenue jump in the final quarter and the transition to new leadership. While the dividend is nominal, the return to profitability and the introduction of an ESOP plan indicate a focus on growth and stability.
Onelife Capital Reports Zero Deviation in Utilization of INR 36 Cr Rights Issue Proceeds
Onelife Capital Advisors Limited has released its Monitoring Agency report for the quarter ended March 31, 2026, confirming the utilization of proceeds from its INR 36 crore Rights Issue. The report, issued by Acuité Ratings & Research, indicates that INR 27.30 crore has been utilized so far, with no deviations from the objects stated in the offer document. Key expenditures include INR 22.50 crore invested in its subsidiary, Dealmoney Commodities, for margin requirements. The remaining INR 8.70 crore is safely held in fixed deposits and monitoring accounts for future deployment.
Key Highlights
Rights Issue of INR 36.00 crore successfully monitored with zero deviations from original objects.
INR 22.50 crore deployed into subsidiary Dealmoney Commodities Private Limited for margin money requirements.
INR 4.80 crore utilized for General Corporate Purposes, including salaries and professional fees.
Unutilized funds of INR 8.70 crore are currently held in HDFC Bank Fixed Deposits and Monitoring Agency accounts.
The Monitoring Agency confirmed that all statutory approvals for the objects have been obtained.
👀 What to Watch
Investors should view this as a positive sign of corporate governance and transparency. The successful deployment of funds into the commodities subsidiary suggests a focus on scaling its core financial services business.
Onelife Capital Board Approves Loans and Investments Totaling ₹14 Crore
Onelife Capital Advisors has approved the deployment of ₹14 crore through various loans and a subsidiary investment. The board sanctioned a ₹5.50 crore loan to Abhidev Consultancy Services at a 12% interest rate and a ₹1.50 crore loan to an individual, Mr. JayKishor Chatuvedi. Furthermore, credit facilities totaling ₹5.50 crore were approved for two NBFCs, alongside a ₹1.50 crore investment in its subsidiary, Dealmoney Real Estate. This move indicates an active capital allocation strategy, though the risk profile of these private loans warrants scrutiny.
Key Highlights
Approved a loan of ₹5.50 crore to Abhidev Consultancy Services Private Limited at 12% interest per annum.
Authorized loans totaling ₹3.50 crore to Gandhi Nagar Leasing and Finance Limited and ₹2.00 crore to Jeevan Jyoti Vanijya Limited.
Granted a personal loan of ₹1.50 crore to Mr. JayKishor Chatuvedi on board-decided terms.
Sanctioned an investment of up to ₹1.50 crore in subsidiary Dealmoney Real Estate Private Limited.
Total capital deployment across all approved items amounts to ₹14 crore.
👀 What to Watch
Investors should monitor the company's ability to recover these loans and the impact on its liquidity position. It is important to evaluate the relationship between the company and the borrowers to ensure there are no corporate governance concerns.
Onelife Capital Board Approves Loans and Investments Totaling ₹14 Crore
Onelife Capital Advisors Limited's board has approved several loans and an investment totaling ₹14 crore. The board sanctioned a loan of ₹5.50 crore to Abhidev Consultancy Services at a 12% interest rate and various loans to NBFCs including Jeevan Jyoti Vanijya and Gandhi Nagar Leasing and Finance. Additionally, a loan of ₹1.50 crore was granted to an individual, Mr. JayKishor Chatuvedi. The company also plans to invest ₹1.50 crore into its subsidiary, Dealmoney Real Estate Private Limited.
Key Highlights
Approved a ₹5.50 crore loan to Abhidev Consultancy Services at 12% interest per annum.
Sanctioned loans totaling ₹3.50 crore to Gandhi Nagar Leasing and Finance Limited across two tranches.
Authorized a ₹2.00 crore loan to Jeevan Jyoti Vanijya Limited and ₹1.50 crore to Mr. JayKishor Chatuvedi.
Approved an investment of up to ₹1.50 crore in subsidiary Dealmoney Real Estate Private Limited.
👀 What to Watch
Investors should monitor the company's cash flow and the relationship between the company and the loan recipients to ensure these are arm's length transactions.
Onelife Capital Receives Listing Approval for 2.4 Crore Rights Issue Shares
Onelife Capital Advisors Limited has received final listing and trading approvals from both BSE and NSE for its recently concluded Rights Issue. A total of 2,40,00,000 equity shares have been admitted to dealings effective from March 25, 2026. These shares were issued at a price of Rs. 15 per share, which includes a face value of Rs. 10 and a premium of Rs. 5. This marks the successful completion of the company's capital-raising exercise and increases the total tradable equity on the exchanges.
Key Highlights
Listing and trading approval granted for 2,40,00,000 equity shares issued via Rights Issue
Shares issued at a total price of Rs. 15 per share (Rs. 10 face value + Rs. 5 premium)
Trading on BSE and NSE commenced on March 25, 2026
Distinctive numbers for the newly listed shares are 13360001 to 37360000
👀 What to Watch
Investors should be aware of the increased equity base and potential dilution of EPS following the listing of these new shares. Monitor the stock for increased liquidity and price volatility as the new shares enter the secondary market.
Onelife Capital Allots 2.4 Crore Equity Shares via Rights Issue at ₹15 Per Share
Onelife Capital Advisors Limited has successfully completed the allotment of 2,40,00,000 equity shares following its Rights Issue. The shares were issued at a price of ₹15 each, including a premium of ₹5 per share. This capital infusion has significantly increased the company's paid-up equity capital from ₹13.36 crore to ₹37.36 crore. The allotment was finalized on March 17, 2026, following the basis of allotment approved by BSE Limited.
Key Highlights
Allotment of 2,40,00,000 Rights Equity Shares at an issue price of ₹15 per share
Paid-up equity share capital increased from ₹13,36,00,000 to ₹37,36,00,000
Total number of equity shares outstanding increased from 1,33,60,000 to 3,73,60,000
The issue price includes a face value of ₹10 and a premium of ₹5 per share
Allotment finalized in consultation with BSE Limited and Registrar KFin Technologies
👀 What to Watch
Investors should monitor the company's deployment of the raised capital and assess the impact of the significant equity dilution on future earnings per share.
Onelife Capital Allots 2.4 Crore Rights Equity Shares at ₹15 Per Share
Onelife Capital Advisors Limited has successfully completed the allotment of 2.4 crore equity shares following its rights issue. The shares were issued at a price of ₹15 each, comprising a face value of ₹10 and a premium of ₹5. This capital infusion has significantly increased the company's paid-up equity share capital from ₹13.36 crore to ₹37.36 crore. The allotment was finalized in accordance with the basis of allotment approved by BSE Limited and the registrar, KFin Technologies.
Key Highlights
Allotted 2,40,00,000 Rights Equity Shares at an issue price of ₹15 per share
Total paid-up equity capital increased from ₹13.36 crore to ₹37.36 crore
Total number of equity shares outstanding increased from 1,33,60,000 to 3,73,60,000
The issue price included a premium of ₹5 per share over the face value of ₹10
Allotment finalized in consultation with BSE Limited and KFin Technologies Limited
👀 What to Watch
Investors should note the significant equity dilution resulting from the nearly 180% increase in share count. Monitor how the company utilizes the newly raised capital to drive growth and offset the impact on Earnings Per Share (EPS).
Onelife Capital Extends Rights Issue Closing Date to March 16, 2026
Onelife Capital Advisors Limited has announced an extension for its ongoing Rights Issue, which originally opened on February 23, 2026. The closing date has been moved from March 06, 2026, to March 16, 2026, to allow more time for shareholders to participate. Additionally, the last date for on-market renunciation of rights entitlements has been extended from March 02, 2026, to March 10, 2026. All other terms and conditions of the Letter of Offer remain unchanged.
Key Highlights
Rights Issue closing date extended from March 06, 2026, to March 16, 2026
On-market renunciation deadline extended from March 02, 2026, to March 10, 2026
The issue originally opened on February 23, 2026
No changes made to the terms and conditions of the Letter of Offer (LOF)
👀 What to Watch
Eligible shareholders who haven't yet applied or renounced their rights now have until March 16 and March 10 respectively. Investors should evaluate the rights offer based on the company's fundamentals before the new deadline.
Onelife Capital Advisors to Raise ₹36 Crore via Rights Issue at ₹15 per Share
Onelife Capital Advisors Limited has submitted its Letter of Offer for a Rights Issue aiming to raise up to ₹36 crore. The company will issue 2.4 crore fully paid-up equity shares at a price of ₹15 per share, which includes a ₹5 premium. The rights entitlement ratio is set at 300 shares for every 167 shares held by eligible shareholders as of the record date, February 16, 2026. The subscription period is scheduled to open on February 23, 2026, and close on March 6, 2026.
Key Highlights
Total issue size of 2,40,00,000 equity shares aggregating to ₹36,00,00,000
Rights ratio of 300:167 for shareholders as of the record date, February 16, 2026
Issue price fixed at ₹15 per share, which is 1.5 times the face value of ₹10
Issue period opens on February 23, 2026, and closes on March 6, 2026
On-market renunciation of rights entitlements is available until March 2, 2026
👀 What to Watch
Existing shareholders should compare the ₹15 offer price with the current market price to decide between subscribing, renouncing, or letting the rights lapse. Given the high ratio of 300:167, non-participation will result in significant equity dilution.
Onelife Capital to Raise ₹36 Crore via Rights Issue; Sets Record Date for Feb 16, 2026
Onelife Capital Advisors Limited has finalized the details for a ₹36 crore Rights Issue, offering 2.4 crore equity shares at ₹15 per share. The company has set February 16, 2026, as the record date to determine eligible shareholders. The entitlement ratio is fixed at 300 shares for every 167 shares held, which will significantly expand the equity base from 1.33 crore to 3.73 crore shares. The subscription window is scheduled to open on February 23 and close on March 6, 2026.
Key Highlights
Total issue size of ₹36 crore through 2,40,00,000 equity shares at ₹15 per share.
Rights Entitlement Ratio of 300:167 for shareholders as of the Feb 16, 2026 record date.
Post-issue equity capital will increase by approximately 180% to 3.73 crore shares.
Rights Issue period is set from February 23, 2026, to March 6, 2026.
On-market renunciation period ends on March 2, 2026.
👀 What to Watch
Investors should evaluate the significant dilution of nearly 180% against the company's intended use of the ₹36 crore capital. Shareholders must decide to subscribe, sell, or renounce their rights before the March 2nd deadline to prevent value loss.
Onelife Capital Advisors Announces ₹36 Crore Rights Issue at ₹15 Per Share
Onelife Capital Advisors has approved a rights issue to raise up to ₹36 crore by issuing 2.4 crore equity shares. The issue price is set at ₹15 per share, which includes a premium of ₹5 over the face value. Eligible shareholders as of the record date, February 16, 2026, can subscribe in a ratio of 300 shares for every 167 shares held. The issue will be open for subscription from February 23 to March 06, 2026.
Key Highlights
Total issue size of ₹36.00 crore through the issuance of 2,40,00,000 equity shares
Rights entitlement ratio fixed at 300:167, leading to significant equity dilution
Issue price of ₹15 per share represents a ₹5 premium over the ₹10 face value
Total outstanding shares to increase from 1,33,60,000 to 3,73,60,000 post-issue
Record date for eligibility is February 16, 2026, with the issue closing on March 06, 2026
👀 What to Watch
Investors should evaluate the issue price of ₹15 against the current market price to decide whether to subscribe or renounce their rights. Be aware that the nearly 180% increase in share capital will lead to substantial earnings dilution.
